|
Volumn 22, Issue 12, 2003, Pages 623-628
|
Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4)1
c
NONE
(United States)
|
Author keywords
AC2993; Exenatide; Exendin 4; Peptides; Placental perfusion; Placental transfer; Pramlintide
|
Indexed keywords
AMYLIN DERIVATIVE;
EXENDIN 4;
INSULIN;
PHENAZONE;
PRAMLINTIDE;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
BLOOD ANALYSIS;
BLOOD PLACENTA BARRIER;
CONTROLLED STUDY;
COTYLEDON;
DIABETES MELLITUS;
DRUG BLOOD LEVEL;
DRUG PENETRATION;
FEMALE;
FETUS;
FETUS BLOOD SAMPLING;
HUMAN;
IMMUNOASSAY;
MOTHER FETUS RELATIONSHIP;
PLACENTAL TRANSFER;
PREGNANCY;
PRIORITY JOURNAL;
AMYLOID;
CATHETERIZATION;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
MATERNAL-FETAL EXCHANGE;
METABOLIC CLEARANCE RATE;
PEPTIDES;
PERFUSION;
PLACENTA;
PLACENTAL CIRCULATION;
PREGNANCY;
VENOMS;
|
EID: 1242330490
PISSN: 09603271
EISSN: None
Source Type: Journal
DOI: 10.1191/0960327103ht402oa Document Type: Article |
Times cited : (35)
|
References (5)
|